President Trump’s comments about artificial intelligence’s potential to drive medical innovation have fueled speculation that Anthropic could be approaching a significant medical breakthrough, although he did not name the company or provide evidence linking it to the development. Asked on Wednesday what he would say to people still cautious about supporting AI, Trump said the technology would create "tremendous innovation medically" and referred to something he had reviewed that morning involving a "pretty unstoppable disease." Anthropic, led by Dario Amodei, is confidentially preparing for an initial public offering (IPO), or first sale of shares to public investors, while private discussions have recently placed its valuation as high as $2 trillion. The speculation could enhance the AI lab’s market appeal, while its model advances may reinforce its competitive position. Investors will be watching for an official Anthropic announcement, updates on the IPO timeline, strategic moves by Amazon and Google, and changes in AI model performance that could affect valuation and market sentiment.